Project Grant HT94252310473
Award Date
7/15/23
Completion Date
7/14/27
Dollars Obligated
$979K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
UPR MONTCLAIR, NJ 07043, USA
Similar Awards
This $2,024,907.00 Cooperative Agreement award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the "STRUCTURE-GUIDED DEVELOPMENT OF POTENT PFPKG INHIBITORS FOR MALARIA CHEMOPROTECTION" project led by Rutgers, The State University of New Jersey (Rutgers), doing business as RBHS-School of Nursing. The project aims to conduct research and development to create new malaria prevention treatments. As the prime awardee, Rutgers...
This $761,027 federal Project Grant award, issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, will support research at Montclair State University to model hemangioblastomas using induced pluripotent stem cells carrying mutations in the von Hippel-Lindau gene. The project aims to advance understanding and treatment of this rare form of brain tumor, which disproportionately impacts military personnel and veterans. The award has a...
This federal Project Grant award for $10,606,583.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research to improve the radical cure of malaria through a combination treatment of tafenoquine and SJ733, a novel ATP4 inhibitor. The University of Kentucky Research Foundation, a non-profit research subsidiary of the University of Kentucky, is the prime awardee for this project spanning from July 1, 2025 to June 30,...
The Project Grant award for $897,448.00, awarded on June 1, 2024 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports Oregon Health & Science University's development of "NEXT-GENERATION ELQS FOR LONG-TERM PROTECTION AGAINST MALARIA." This research initiative aims to advance novel treatments and protective measures against malaria, a key focus area for the Defense Health Agency's military medical research initiatives....
This federal Project Grant award of $384,063.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research conducted by The Pennsylvania State University (Penn State) to investigate the direct genetic modification of Plasmodium sporozoites using mRNA/lipid nanoparticles. The research aims to transform healthcare for military service members and the broader public by advancing innovative biomedical solutions. The project...
This $732,500.00 Project Grant award from the Defense Health Agency supports research by Mississippi State University on the "Neurochemical and Behavioral Effects Following Repeated-Dose Pyridostigmine Bromide and Sublethal Organophosphate Challenge." The award is funded through the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to improve healthcare for Service Members and the public. Over the 3-year...
This federal Project Grant award of $249,999.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is supporting research conducted by the University of Maryland, Baltimore (UMB) to gain insights into multiple sclerosis pathology. The research project will leverage 7-T MRI and multiomics analysis of serologic samples to advance the understanding of this neurological disorder. The award period runs from August 15, 2024 to August 14,...
The Department of the Army Medical Command awarded a $5,753,844 Project Grant under the Military Medical Research and Development federal grant program (CFDA 12.420) to the Portland VA Research Foundation, Inc. for the period of July 1, 2022 to June 30, 2026. The grant will support the preclinical development of novel liver-stage active antimalarial drugs with radical cure potential. Through innovative research, the goal is to transform healthcare for service members and the public by...
This $542,247 federal Project Grant award was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support the development of boron-doped diamond electrode arrays for malaria detection in saliva and urine. The award was granted to Fraunhofer USA, Inc., a non-profit applied research organization, to conduct this research and development work over a 2-year period from March 1, 2025 to February 28, 2027. As a subcontractor, Fraunhofer...
This Project Grant award of $999,996.00 from the Defense Health Agency under the Military Medical Research and Development Program (CFDA 12.420) is supporting research at the University of Illinois to investigate the mechanism governing the association between viral respiratory infection relapse and disease progression in persons with multiple sclerosis (MS). The research aims to transform health care for service members and the American public through innovative and impactful research, as...